Clinical & Diagnostic

Tucuvi Joins Microsoft for Startups Pegasus Programme to Scale AI Care Management

Tucuvi brings a differentiated clinical approach to conversational AI within the Microsoft Pegasus Program, extending voice AI beyond administrative interactions into clinically governed care management...

BioLab Holdings Launches EmeraNova to Advance the Future of Tissue Restoration

Expanded vision reflects focus beyond wound care to advancing innovation across the full tissue restoration journey ...

Fuse Oncology Expands FuseRx to Streamline Radiation Care Workflows

Beyond treatment intent, the complete clinical workflow will include tools for the physician, physicist, dosimetrist, therapist and nurse. It builds on collaboration with the University of Michigan and Cone Health, part of Risant Health...

Paragonix SherpaPak Analysis Highlights Potential Benefits Beyond Organ Preservation

Heart transplantation remains the definitive, gold-standard treatment for eligible patients with advanced heart failure...

Mayo Clinic Laboratories and PAH Expand Access to Advanced Genomic Testing

Genomics is a central focus of the collaboration, delivered through LifeStrands Genomics...

RIVANNA’s AI-Enabled Ultrasound Guidance Gains New CMS Inpatient Code

Effective October 1, 2026, ICD-10-PCS code XEZU3HC establishes the first dedicated national inpatient coding category for real-time ultrasound navigation with continuous needle tracking...

Mayo Clinic and Thermo Fisher Scientific Launch Precure to Advance Population-Scale Precision Medicine

Initiative will combine one million biospecimens with longitudinal clinical data and advanced proteomics technologies to uncover early biological signals of disease...

Germfree integrates Smarthood with Wolters Kluwer Simplifi+ to automate IV compounding workflows

The certified integration combines sterile compounding hardware, gravimetric and volumetric workflows, and preparation-level video traceability to support safer and more efficient hospital pharmacy operations....

SkylineDx Expands Direct US Commercial Presence for Merlin CP-GEP

SkylineDx completes transition from third-party commercialization to a fully integrated U.S. commercial model, establishing a dedicated sales, marketing and clinical organization of more than 25 professionals strategically positioned across key U.S. markets...

Kelun-Biotech Reports Positive Phase 2 Results for Twice-Yearly Asthma Therapy

The first Phase 3 study of SKB378/WIN378 has been initiated evaluating two twice-yearly doses. A second Phase 3 trial is planned to begin in the first half of 2027...